Taiyen Biotech Co Ltd (1737) — Cash Flow Quality Index
Taiyen Biotech Co Ltd (1737) has a Cash Flow Quality Index of 1.36x as of December 2025. Operating cash flow of NT$194.08 Million exceeds net income of NT$143.09 Million, indicating high earnings quality where cash backs reported profits. Explore 1737 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Taiyen Biotech Co Ltd Cash Flow Quality Index (2003–2025)
Historical Cash Flow Quality Index for Taiyen Biotech Co Ltd across 22 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Taiyen Biotech Co Ltd (1737) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Taiyen Biotech Co Ltd (2003–2025)
Year-by-year earnings quality comparison for Taiyen Biotech Co Ltd. For live market cap and the full company financial profile, see Taiyen Biotech Co Ltd market cap and net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.18x | NT$473.77 Million | NT$399.87 Million | ▼ -33.3% |
| 2024 | 1.78x | NT$660.12 Million | NT$371.52 Million | ▲ +17.4% |
| 2023 | 1.51x | NT$454.54 Million | NT$300.39 Million | ▲ +11.2% |
| 2022 | 1.36x | NT$580.69 Million | NT$426.70 Million | ▲ +15.6% |
| 2021 | 1.18x | NT$600.08 Million | NT$509.92 Million | ▲ +60.9% |
| 2020 | 0.73x | NT$339.36 Million | NT$464.04 Million | ▼ -5.3% |
| 2019 | 0.77x | NT$330.81 Million | NT$428.55 Million | ▼ -8.8% |
| 2018 | 0.85x | NT$449.83 Million | NT$531.59 Million | ▼ -40.6% |
| 2017 | 1.43x | NT$607.87 Million | NT$426.48 Million | ▲ +4.1% |
| 2016 | 1.37x | NT$568.06 Million | NT$414.82 Million | ▲ +13.9% |
| 2015 | 1.20x | NT$383.93 Million | NT$319.34 Million | ▼ -20.4% |
| 2014 | 1.51x | NT$371.06 Million | NT$245.76 Million | ▲ +6.6% |
| 2013 | 1.42x | NT$203.21 Million | NT$143.54 Million | ▼ -28.4% |
| 2012 | 1.98x | NT$154.46 Million | NT$78.11 Million | ▲ +56.0% |
| 2011 | 1.27x | NT$246.09 Million | NT$194.07 Million | ▼ -23.5% |
| 2010 | 1.66x | NT$300.89 Million | NT$181.41 Million | ▼ -2.8% |
| 2009 | 1.71x | NT$358.02 Million | NT$209.77 Million | ▼ -75.1% |
| 2007 | 6.86x | NT$322.49 Million | NT$46.99 Million | ▲ +407.6% |
| 2006 | 1.35x | NT$462.88 Million | NT$342.33 Million | ▼ -96.4% |
| 2005 | 37.26x | NT$575.91 Million | NT$15.46 Million | ▲ +1254.2% |
| 2004 | 2.75x | NT$2.84 Billion | NT$1.03 Billion | ▼ -22.7% |
| 2003 | 3.56x | NT$3.42 Billion | NT$960.78 Million | — |